메뉴 건너뛰기




Volumn 421, Issue 2, 2012, Pages 556-565

High-performance liquid chromatography-tandem mass spectrometry assay of fatty acid amide hydrolase (FAAH) in blood: FAAH inhibition as clinical biomarker

Author keywords

Anandamide; Arachidonoylethanolamide; Bioanalytical; Biomarkers; Enzyme activity assay; Fatty acid amide hydrolase (FAAH); HPLC MS MS; Radiometric; Time dependent inhibition

Indexed keywords

AMIDES; BIOMARKERS; BLOOD; BRAIN; ELECTROSPRAY IONIZATION; ENZYME ACTIVITY; FATTY ACIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLASES; MASS SPECTROMETRY; RADIOMETRY; RATS;

EID: 84859721217     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.10.042     Document Type: Article
Times cited : (11)

References (32)
  • 1
    • 84884474728 scopus 로고    scopus 로고
    • Pharmacological actions of cannabinoids
    • Springer-Verlag, Heidelberg, Germany
    • R.G. Pertwee, Pharmacological actions of cannabinoids, Handbook of Experimental Pharmacology, vol. 168, Springer-Verlag, Heidelberg, Germany, 2005. pp. 1-51.
    • (2005) Handbook of Experimental Pharmacology , vol.168 , pp. 1-51
    • Pertwee, R.G.1
  • 3
    • 54049149312 scopus 로고    scopus 로고
    • Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown
    • E.A. Placzek, Y. Okamoto, N. Ueda, E.L. Barker, Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown, Neuropharmacology 55 (2008) 1095-1104.
    • (2008) Neuropharmacology , vol.55 , pp. 1095-1104
    • Placzek, E.A.1    Okamoto, Y.2    Ueda, N.3    Barker, E.L.4
  • 4
    • 1842685334 scopus 로고    scopus 로고
    • Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat
    • DOI 10.1016/j.pain.2004.01.020, PII S030439590400051X
    • D.A. Scott, C.E. Wright, J.A. Angus, Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat, Pain 109 (2004) 124-131. (Pubitemid 38479778)
    • (2004) Pain , vol.109 , Issue.1-2 , pp. 124-131
    • Scott, D.A.1    Wright, C.E.2    Angus, J.A.3
  • 5
    • 2242490907 scopus 로고    scopus 로고
    • Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling
    • DOI 10.1126/science.1076535
    • M.H. Bracey, M.A. Hanson, K.R. Masuda, R.C. Stevens, B.F. Cravatt, Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling, Science 298 (2002) 1793-1796. (Pubitemid 35404124)
    • (2002) Science , vol.298 , Issue.5599 , pp. 1793-1796
    • Bracey, M.H.1    Hanson, M.A.2    Masuda, K.R.3    Stevens, R.C.4    Cravatt, B.F.5
  • 6
    • 0029904838 scopus 로고    scopus 로고
    • Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
    • DOI 10.1038/384083a0
    • B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, N.B. Gilula, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature 384 (1996) 83-87. (Pubitemid 26374593)
    • (1996) Nature , vol.384 , Issue.6604 , pp. 83-87
    • Cravatt, B.F.1    Giang, D.K.2    Mayfield, S.P.3    Boger, D.L.4    Lerner, R.A.5    Gilula, N.B.6
  • 10
    • 15744385109 scopus 로고    scopus 로고
    • Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 30-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation
    • DOI 10.1124/jpet.104.078980
    • D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, G. Tarzia, D. Piomelli, Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 30-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation, J. Pharmacol. Exp. Ther. 313 (2005) 352-358. (Pubitemid 40411361)
    • (2005) Journal of Pharmacology and Experimental Therapeutics , vol.313 , Issue.1 , pp. 352-358
    • Fegley, D.1    Gaetani, S.2    Duranti, A.3    Tontini, A.4    Mor, M.5    Tarzia, G.6    Piomelli, D.7
  • 11
    • 67650732783 scopus 로고    scopus 로고
    • Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders
    • K. Ahn, D.S. Johnson, B.F. Cravatt, Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders, Expert Opin. Drug Discov. 4 (2009) 763-784.
    • (2009) Expert Opin. Drug Discov. , vol.4 , pp. 763-784
    • Ahn, K.1    Johnson, D.S.2    Cravatt, B.F.3
  • 12
    • 0036221971 scopus 로고    scopus 로고
    • CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
    • DOI 10.1016/S0304-3959(01)00454-7, PII S0304395901004547
    • N. Clayton, F.H. Marshall, C. Bountra, C.T. O'Shaughnessy, CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain, Pain 96 (2002) 253-260. (Pubitemid 34327871)
    • (2002) Pain , vol.96 , Issue.3 , pp. 253-260
    • Clayton, N.1    Marshall, F.H.2    Bountra, C.3    O'Shaughnessy, C.T.4
  • 15
    • 0038582327 scopus 로고    scopus 로고
    • A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain
    • DOI 10.1016/S0304-3959(02)00450-5
    • L.J. Kehl, D.T. Hamamoto, P.W. Wacnik, D.L. Croft, B.D. Norsted, G.L. Wilcox, D.A. Simone, A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain, Pain 103 (2003) 175-186. (Pubitemid 36579097)
    • (2003) Pain , vol.103 , Issue.1-2 , pp. 175-186
    • Kehl, L.J.1    Hamamoto, D.T.2    Wacnik, P.W.3    Croft, D.L.4    Norsted, B.D.5    Wilcox, G.L.6    Simone, D.A.7
  • 16
    • 0032056333 scopus 로고    scopus 로고
    • 9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats
    • DOI 10.1016/S0091-3057(97)00583-2, PII S0091305797005832
    • F.L. Smith, K. Fujimori, J. Lowe, S.P. Welch, Characterization of δ9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats, Pharmacol. Biochem. Behav. 60 (1998) 183-191. (Pubitemid 28236629)
    • (1998) Pharmacology Biochemistry and Behavior , vol.60 , Issue.1 , pp. 183-191
    • Smith, F.L.1    Fujimori, K.2    Lowe, J.3    Welch, S.P.4
  • 26
    • 67649371450 scopus 로고    scopus 로고
    • Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization
    • J. Palandra, J. Prusakiewicz, J.S. Ozer, Y. Zhang, T.G. Heath, Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization, J. Chromatogr. B 877 (2009) 2052-2060.
    • (2009) J. Chromatogr. B , vol.877 , pp. 2052-2060
    • Palandra, J.1    Prusakiewicz, J.2    Ozer, J.S.3    Zhang, Y.4    Heath, T.G.5
  • 27
    • 3242664227 scopus 로고    scopus 로고
    • A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase
    • DOI 10.1016/j.jbbm.2004.04.020, PII S0165022X04001162
    • L. Boldrup, S.J. Wilson, A.J. Barbier, C.J. Fowler, A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase, J. Biochem. Biophys. Methods 60 (2004) 171-177. (Pubitemid 38953060)
    • (2004) Journal of Biochemical and Biophysical Methods , vol.60 , Issue.2 , pp. 171-177
    • Boldrup, L.1    Wilson, S.J.2    Barbier, A.J.3    Fowler, C.J.4
  • 28
    • 0033557834 scopus 로고    scopus 로고
    • A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity
    • DOI 10.1006/abio.1998.2964
    • M. Maccarrone, M. Bari, A.F. Agro, A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity, Anal. Biochem. 267 (1999) 314-318. (Pubitemid 29095878)
    • (1999) Analytical Biochemistry , vol.267 , Issue.2 , pp. 314-318
    • Maccarrone, M.1    Bari, M.2    Finazzi, A.A.3
  • 29
    • 23744501056 scopus 로고    scopus 로고
    • Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: Evidence that VDM11 acts as an FAAH substrate
    • DOI 10.1038/sj.bjp.0706253
    • S. Vandevoorde, C.J. Fowler, Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate, Br. J. Pharmacol. 145 (2005) 885-893. (Pubitemid 41129010)
    • (2005) British Journal of Pharmacology , vol.145 , Issue.7 , pp. 885-893
    • Vandevoorde, S.1    Fowler, C.J.2
  • 31
    • 0003484310 scopus 로고    scopus 로고
    • Food and Drug Administration, FDA, U.S. Department of Health and Human Services, Rockville, MD
    • Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation. FDA, U.S. Department of Health and Human Services, Rockville, MD, 2001.
    • (2001) Guidance for Industry: Bioanalytical Method Validation
  • 32
    • 67649854862 scopus 로고    scopus 로고
    • Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol
    • M.L. Yates, E.L. Barker, Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol, Mol. Pharmacol. 76 (2009) 11-17.
    • (2009) Mol. Pharmacol. , vol.76 , pp. 11-17
    • Yates, M.L.1    Barker, E.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.